Self-administered C1 esterase inhibitor concentrates for the management of hereditary angioedema: usability and patient acceptance

Self-administered C1 esterase inhibitor concentrates for the management of hereditary angioedema: usability and patient acceptance

Huamin Henry Li Institute for Asthma and Allergy, Chevy Chase, MD, USA Abstract: Hereditary angioedema (HAE) is a rare genetic disease characterized by episodic subcutaneous or submucosal swelling. The primary cause for the most common form of HAE is a deficiency in functional C1 esterase inhibito...

Full description

Bibliographic Details
Main Author: Li HH
Format: Article
Language:English
Published: Dove Medical Press 2016-09-01
Series:Patient Preference and Adherence
Subjects:
C1 inhibitor concentrate
hereditary angioedema
disease management
first-line
prophylaxis
self-administration
Online Access:https://www.dovepress.com/self-administered-c1-esterase-inhibitor-concentrates-for-the-managemen-peer-reviewed-article-PPA

Internet

https://www.dovepress.com/self-administered-c1-esterase-inhibitor-concentrates-for-the-managemen-peer-reviewed-article-PPA

Similar Items